These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 31383281)

  • 21. The potential role of bacteria in pancreatic cancer: a systematic review.
    Li P; Shu Y; Gu Y
    Carcinogenesis; 2020 Jun; 41(4):397-404. PubMed ID: 32034405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut microbiota imbalance and colorectal cancer.
    Gagnière J; Raisch J; Veziant J; Barnich N; Bonnet R; Buc E; Bringer MA; Pezet D; Bonnet M
    World J Gastroenterol; 2016 Jan; 22(2):501-18. PubMed ID: 26811603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma.
    Lv J; Guo L; Liu JJ; Zhao HP; Zhang J; Wang JH
    World J Gastroenterol; 2019 May; 25(18):2149-2161. PubMed ID: 31143067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Overview of the Dichotomous Role of Microbiota in Cancer Progression and Management.
    Jain P; Mohapatra S; Farooq U; Hassan N; Mirza MA; Iqbal Z
    Curr Cancer Drug Targets; 2024 Feb; ():. PubMed ID: 38409691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of microbial dysbiosis in carcinogenesis & cancer therapies.
    Vimal J; Himal I; Kannan S
    Indian J Med Res; 2020 Dec; 152(6):553-561. PubMed ID: 34145094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Progress in the study of signal pathways for chronic inflammation-associated pancreatic carcinogenesis].
    Xu QQ; Zhou ZS; Xiang M
    Yao Xue Xue Bao; 2016 Feb; 51(2):174-81. PubMed ID: 29856196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P. Gingivalis May Increase Pancreatic Cancer Risk.
    J Calif Dent Assoc; 2016 Jun; 44(6):324. PubMed ID: 27451541
    [No Abstract]   [Full Text] [Related]  

  • 28. The oral microbiome, pancreatic cancer and human diversity in the age of precision medicine.
    Herremans KM; Riner AN; Cameron ME; McKinley KL; Triplett EW; Hughes SJ; Trevino JG
    Microbiome; 2022 Jun; 10(1):93. PubMed ID: 35701831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Microbiome in Pancreatic Cancer-Implications for Diagnosis and Precision Bacteriophage Therapy for This Low Survival Disease.
    Kabwe M; Dashper S; Tucci J
    Front Cell Infect Microbiol; 2022; 12():871293. PubMed ID: 35663462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of Commensal Microbiota in Pancreas Homeostasis and Pancreatic Pathologies.
    Leal-Lopes C; Velloso FJ; Campopiano JC; Sogayar MC; Correa RG
    J Diabetes Res; 2015; 2015():284680. PubMed ID: 26347203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiota, oral microbiome, and pancreatic cancer.
    Michaud DS; Izard J
    Cancer J; 2014; 20(3):203-6. PubMed ID: 24855008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suicide journey of H. pylori through gastric carcinogenesis: the role of non-H. pylori microbiome and potential consequences for clinical practice.
    de Assumpção PP; Araújo TMT; de Assumpção PB; Barra WF; Khayat AS; Assumpção CB; Ishak G; Nunes DN; Dias-Neto E; Coelho LGV
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1591-1597. PubMed ID: 31114971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral Microbiota Variation: A Risk Factor for Development and Poor Prognosis of Esophageal Cancer.
    Song X; Greiner-Tollersrud OK; Zhou H
    Dig Dis Sci; 2022 Aug; 67(8):3543-3556. PubMed ID: 34505256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helicobacter pylori infection and development of pancreatic cancer.
    de Martel C; Llosa AE; Friedman GD; Vogelman JH; Orentreich N; Stolzenberg-Solomon RZ; Parsonnet J
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1188-94. PubMed ID: 18483341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The microbiome and hepatobiliary-pancreatic cancers.
    Mima K; Nakagawa S; Sawayama H; Ishimoto T; Imai K; Iwatsuki M; Hashimoto D; Baba Y; Yamashita YI; Yoshida N; Chikamoto A; Baba H
    Cancer Lett; 2017 Aug; 402():9-15. PubMed ID: 28527946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral bacteria in pancreatic cancer: mutagenesis of the p53 tumour suppressor gene.
    Öğrendik M
    Int J Clin Exp Pathol; 2015; 8(9):11835-6. PubMed ID: 26617937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of microbiota-immunity axis in pancreatic cancer management.
    Bartolini I; Nannini G; Risaliti M; Matarazzo F; Moraldi L; Ringressi MN; Taddei A; Amedei A
    World J Gastroenterol; 2022 Aug; 28(32):4527-4539. PubMed ID: 36157926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Association Between Oral Anaerobic Bacteria and Pancreatic Cancer.
    Ogrendik M
    World J Oncol; 2023 Jun; 14(3):174-177. PubMed ID: 37350809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut microbiota and mTOR signaling: Insight on a new pathophysiological interaction.
    Noureldein MH; Eid AA
    Microb Pathog; 2018 May; 118():98-104. PubMed ID: 29548696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer.
    Lindkvist B; Johansen D; Borgström A; Manjer J
    BMC Cancer; 2008 Nov; 8():321. PubMed ID: 18986545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.